Castleark Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-115,901
Closed -$4.27M 370
2018
Q3
$4.27M Sell
115,901
-124,094
-52% -$5.42M 0.12% 207
2018
Q2
$12.1M Sell
239,995
-55,093
-19% -$2.43M 0.37% 87
2018
Q1
$10.8M Sell
295,088
-68,556
-19% -$2.1M 0.34% 89
2017
Q4
$10.3M Sell
363,644
-44,397
-11% -$1.05M 0.31% 113
2017
Q3
$7.9M Buy
408,041
+84,120
+26% +$1.41M 0.25% 141
2017
Q2
$5.43M Buy
+323,921
New +$4.37M 0.18% 170

Other funds holding AXGN

Castleark Management's AXGN Position: Q4 2018 in Review

Castleark Management sold out of Axogen (AXGN) in Q4 2018, closing a stake of 115,901 shares — an estimated $4.27M sold.

Castleark Management first reported a position in AXGN in Q2 2017 and held it in 6 quarters. The position peaked at $12.1M in Q2 2018. 146 funds tracked by Wall St. Rank hold AXGN as of Q4 2018.

  • Castleark Management reported no remaining Axogen position as of Q4 2018 after selling out during the quarter.
  • Castleark Management sold 115,901 Axogen shares in Q4 2018, an estimated $4.27M.
  • Castleark Management first reported a position in Axogen in Q2 2017 and held it in 6 quarters.
  • Castleark Management's Axogen position peaked at $12.1M in Q2 2018.
  • 146 funds tracked by Wall St. Rank held Axogen as of Q4 2018.

Based on Castleark Management's 13F filing for Q4 2018, filed 12 Feb 2019.